Irvingia Gabonensis & Fucoxanthin Capsules combine a botanical extract derived from African mango (Irvingia gabonensis) seeds with fucoxanthin, a naturally occurring carotenoid associated with brown seaweeds. This combination is used in nutraceutical formulations where plant-derived botanical ingredients and marine-derived carotenoids are brought together in a convenient capsule dosage form. Commercial formulations containing these two ingredients are available, although the amount of each active ingredient varies according to the specific formulation.
MEDIOCON INC supplies Irvingia Gabonensis & Fucoxanthin Capsules for nutraceutical and dietary-supplement applications, subject to the applicable product formulation and regulatory requirements. Irvingia gabonensis is also known as African mango, wild mango or bush mango, and its seeds are used as the source material for commercial extracts. Extracts are available in different concentration ratios, including documented 10:1 preparations, and may be supplied as fine light-brown to brownish-yellow powders before incorporation into a finished capsule formulation.
Fucoxanthin is a marine carotenoid naturally associated with brown seaweeds. Unlike the Irvingia botanical extract, fucoxanthin is a defined chemical compound with the molecular formula C42H58O6, molecular weight approximately 658.9 g/mol, and CAS number 3351-86-8. These chemical identifiers refer specifically to fucoxanthin and should not be applied to the complete combination capsule or to the Irvingia extract.
The combination is particularly relevant for manufacturers developing botanical and carotenoid-based nutraceutical products. Commercial formulations demonstrate that Irvingia gabonensis seed extract and fucoxanthin can be incorporated together into capsule products, but the dosage, extract ratio, standardization, capsule shell and excipient system can differ substantially between products. Therefore, the final MEDIOCON product specification should be controlled by the approved formulation, Certificate of Analysis and applicable regulatory requirements rather than by another company's commercial label.
MEDIOCON INC can supply this product in accordance with the customer's required formulation and technical specifications. Available documentation may include the Certificate of Analysis, product specification, technical data sheet, ingredient information and other applicable quality documents. For commercial procurement, customers should confirm the exact Irvingia extract ratio, fucoxanthin assay, capsule fill weight, excipients, packaging configuration and batch-specific analytical results before final approval.
Irvingia gabonensis Extract
Another documented 10:1 Irvingia extract specification reports moisture NMT 8.0%, ash NMT 8.0%, heavy metals NMT 10 ppm, lead NMT 3 ppm, arsenic NMT 1 ppm, cadmium NMT 1 ppm and mercury NMT 0.1 ppm. These should be treated as reference raw-material specifications rather than automatically as MEDIOCON's finished-product specification.
Fucoxanthin
| Parameter | Specification |
|---|---|
| Appearance | Capsules containing a botanical |
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Irvingia Gabonensis & Fucoxanthin Capsules Manufacturer & Supplier in India | MEDIOCON INC (CAS 192230-28-7*) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Irvingia Gabonensis & Fucoxanthin Capsules Manufacturer & Supplier in India | MEDIOCON INC is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing before release with a Certificate of Analysis.
Export Markets
Quality & Compliance